Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on September 1, 2026

Sep. 1, 2026

Veterans & Individuals Living with Mental Health Conditions Face Disability Benefit Challenges, Says Marc Whitehead

Indeterminate EIN Presswire

Sep. 1, 2026

Infinite Recovery Expands Outpatient Addiction Treatment in San Antonio, Texas

Indeterminate EIN Presswire

Sep. 1, 2026

Texas Voters Support Action on Healthcare Prices, New Texas 2036 Poll Finds

Indeterminate EIN Presswire

Sep. 1, 2026

Complete 6-Month DEScover Results for Solaris DE to be Presented at CIRSE 2026

Indeterminate EIN Presswire

Sep. 1, 2026

Austin Plastic Surgeon on Surgical Solutions After Weight Loss

Indeterminate EIN Presswire

Sep. 1, 2026

Austin Black Physicians Association Partners with Ascension Seton to Advance Black Physicians and Healthier Communities

Indeterminate EIN Presswire

Sep. 1, 2026

Desert Hope Treatment Center Addresses Community Need for Increased Addiction Services with New Virtual Program

Indeterminate GlobeNewswire

Sep. 1, 2026

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Indeterminate GlobeNewswire

Sep. 1, 2026

Qwaiting Platform Adopted by 65,000+ Businesses Across Key Service Industries

Indeterminate EIN Presswire

Sep. 1, 2026

Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

HWH International Inc. Announces Executive Leadership Transition

Indeterminate GlobeNewswire

Sep. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Indeterminate GlobeNewswire

Sep. 1, 2026

Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

STERIS to Present at the Morgan Stanley Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis annonce sa participation à plusieurs conférences investisseurs

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Tarsus to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire